Status:
COMPLETED
Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder
Lead Sponsor:
Goethe University
Collaborating Sponsors:
Heidelberg University
Radboud University Medical Center
Conditions:
Attention-Deficit / Hyperactivity Disorder
Depression
Eligibility:
All Genders
14-45 years
Phase:
PHASE2
Brief Summary
Depression and obesity are very common among adolescents and young adults with attention-deficit/ hyperactivity disorder (ADHD). However, intervention programmes to prevent these comorbid disorders ra...
Detailed Description
The risk for comorbid major depressive disorder and obesity is increased in adolescents and adults with attention-deficit/ hyperactivity disorder (ADHD), and adolescent ADHD predicts adults major depr...
Eligibility Criteria
Inclusion
- Diagnosis of ADHD according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria
- Stable treatment as usual comprising pharmacotherapy, group based or individual cognitive behavioural therapy (not including elements of bright light therapy or exercise)
Exclusion
- Intelligence Quotient (IQ) below 75
- Any severe (comorbid) psychiatric disorder with necessary additional psychopharmaco or daycare/ inpatient therapy beyond treatment as usual
- Severe medical/ neurological condition not allowing bright light therapy or exercise
- History of epilepsy
- Use of antipsychotics, antiepileptic or photosensitising medication
- Substance abuse/ dependency
Key Trial Info
Start Date :
March 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT03371810
Start Date
March 13 2017
End Date
August 31 2020
Last Update
October 19 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Goethe University Hospital Frankfurt, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, and Department of Psychiatry, Psychosomatic Medicine and Psychotherapy
Frankfurt am Main, Germany
2
Radboud University Medical Centre, Karakter Child and Adolescent Psychiatry, and Department of Psychiatry
Nijmegen, Netherlands
3
Vall d'Hebron Research Institute, Group of Psychiatry, Mental Health and Addiction
Barcelona, Spain
4
King's College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience
London, United Kingdom